| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 225 | 3.003 | 22.295 | 40.426 | 67.325 | 86.698 |
| Total Income - EUR | - | - | - | - | 225 | 3.003 | 22.296 | 40.428 | 67.328 | 86.723 |
| Total Expenses - EUR | - | - | - | - | 146 | 3.423 | 10.303 | 21.695 | 31.852 | 40.282 |
| Gross Profit/Loss - EUR | - | - | - | - | 80 | -420 | 11.993 | 18.733 | 35.476 | 46.440 |
| Net Profit/Loss - EUR | - | - | - | - | 73 | -510 | 11.736 | 18.329 | 34.803 | 41.029 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Nutrisanadiab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 753 | 1.497 | 2.837 | 2.187 | 2.841 |
| Current Assets | - | - | - | - | 290 | 2.501 | 14.986 | 20.755 | 38.805 | 64.777 |
| Inventories | - | - | - | - | 16 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 163 | 3.718 | 177 |
| Cash | - | - | - | - | 275 | 2.501 | 14.986 | 20.592 | 35.087 | 64.601 |
| Shareholders Funds | - | - | - | - | 115 | -398 | 11.347 | 18.420 | 34.852 | 58.205 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 175 | 3.651 | 5.136 | 5.173 | 6.141 | 9.414 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nutrisanadiab S.r.l.